Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03879005
Other study ID # SRF using DTPA Vs DMSA
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date April 2019
Est. completion date October 2019

Study information

Verified date March 2019
Source Assiut University
Contact Marwa F Abd El Hay
Phone 0102291658
Email f.marwa1992@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To evaluate split renal function using Tc-99m DTPA versus Tc-99m DMSA.


Description:

Split renal function (SPR) is a determination of the relative contribution of each of the two kidneys . It gives a useful information in several conditions such as evaluating unilateral renal disorders, assessing individual kidney function before and after intervention, and before live donor nephrectomy. Different radiopharmaceuticals such as technetium‐99m dimercaptosuccinic acid (99mTc‐DMSA), technetium‐99m diethylenetriaminepentaaceticacid (99mTc‐DTPA), technetium‐99m mercaptoacetyltriglycine (99mTc‐MAG3), Iodine 131 orthoiodohippurate and more recently technetium‐99 m ethylenedicysteine (99mTc‐EC) were used, However, 99mTc‑DMSA as a static renal agent is considered the most reliable method to measure relative renal function and the most appropriate tracer for renal cortical imaging . In some papers, it is emphasized that relative renal function calculated with 99mTc‑DTPA is as reliable as 99mTc‑DMSA .‬ The investigators design the study to evaluate the difference in estimation of split renal function using the available two radiopharmaceuticals: Tc-99m DTPA and Tc-99m DMSA.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 25
Est. completion date October 2019
Est. primary completion date September 2019
Accepts healthy volunteers No
Gender All
Age group 2 Months to 80 Years
Eligibility Inclusion Criteria:

1. Kidney patients of wide age ranges.

2. Patients with renal disorders who referred for DMSA and DTPA split renal function.

3. Patients able to sleep in a fixed position for 20 minutes.

Exclusion Criteria:

1. Children unable to sit calm without movement during imaging.

2. Severely ill patients.

3. Patients with allergy to one or more of material method.

Study Design


Related Conditions & MeSH terms

  • The Difference in Estimation of Split Renal Function Using the Two Radiopharmaceuticals:Tc-99m DTPA & Tc-99m DMSA in Kidney Patients

Intervention

Other:
renal scintigraphy
99mTc-DTPA Scintigraphy Five mci of 99mTc-DTPA will be injected by IV route together with diuretic. Dose will be adjusted according to the age and weight of the patients. A total of 20 min dynamic imaging followed by calculation of GFR and SRF according to the built-in processing protocol Gate's method. 99mTc-DMSA scintigraphy Five mci of 99mTc- DMSA will be injected by IV route with adjustment according to age and weight. Static images will be acquired in the posterior, anterior, andposterior oblique projections for 60 s each.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

References & Publications (4)

Ardela Díaz E, Miguel Martínez B, Gutiérrez Dueñas JM, Díez Pascual R, García Arcal D, Domínguez Vallejo FJ. [Comparative study of differential renal function by DMSA and MAG-3 in congenital unilateral uropathies]. Cir Pediatr. 2002 Jul;15(3):118-21. Span — View Citation

Cao X, Xu X, Grant FD, Treves ST. Estimation of Split Renal Function With (99m)Tc-DMSA SPECT: Comparison Between 3D Volumetric Assessment and 2D Coronal Projection Imaging. AJR Am J Roentgenol. 2016 Dec;207(6):1324-1328. Epub 2016 Sep 13. — View Citation

Çelik T, Yalçin H, Günay EC, Özen A, Özer C. Comparison of the Relative Renal Function Calculated with 99mTc-Diethylenetriaminepentaacetic Acid and 99mTc-Dimercaptosuccinic Acid in Children. World J Nucl Med. 2014 Sep;13(3):149-53. doi: 10.4103/1450-1147. — View Citation

Lee WG, Kim JH, Kim JM, Shim KM, Kang SS, Chae HI, Choi SH. Renal uptakes of 99mTc-MAG3, 99mTc-DTPA, and 99mTc-DMSA in rabbits with unilateral ureteral obstruction. In Vivo. 2010 Mar-Apr;24(2):137-9. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Split renal function using 99mTc-DTPA versus 99mTc-DMSA in kidney patients of wide age ranges. To emphasize that split renal function calculated with Tc-99m DTPA is as reliable as Tc-99m DMSA one year